Controllable switching between planar and helical flagellar swimming of a soft robotic sperm.

Sperm cells undergo a wide variety of swimming patterns by a beating flagellum to maintain high speed regardless of the rheological and physical properties of the background fluid. In this work, we develop and control a soft robotic sperm that undergoes controllable switching between swimming modes like biological sperm cells. The soft robotic sperm consists of a magnetic head and an ultra-thin flexible flagellum, and is actuated using external magnetic fields. We observe that out-of-plane wobbling of the head results in helical wave propagation along the flagellum, whereas in-plane wobbling achieves planar wave propagation. Our theoretical predictions and experimental results show the ability of the soft robotic sperm to change its swimming speed by tuning the beating frequency of its flagellum and the propulsion pattern. The average speed of the soft robotic sperm increases by factors of 2 and 1.2 in fluids with viscosity of 1 Pa.s and 5 Pa.s at relatively low actuation frequencies, respectively, when they switch between planar to helical flagellar propulsion.

Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.

BACKGROUND: The interaction of advanced glycation end products (AGEs) and its receptor (RAGE) has played an important role in the pathogenesis of diabetes and its complications. A soluble form of RAGE (sRAGE) has been reported as a decoy receptor for AGEs. Oxidative stress is demonstrated in pathological condition such as atherosclerosis and diabetes mellitus. It has been suggested to be involved in the pathogenesis of both macro- and microvascular complications. This study was designed to evaluate the effect of glycemic control on sRAGE and oxidative stress markers in type 2 diabetic patients. METHODS: Seventy patients with type 2 diabetes and 20 healthy subjects were recruited into the study. Blood glutathione (GSH) and plasma total nitric oxide (NOx) levels were measured using commercially available colorimetric kits, blood superoxide dismutase (SOD) activity was measured by the method of Marklund and Marklund, and plasma C-peptide, oxidized LDL (ox-LDL), sRAGE, and VCAM-1 levels were measured using competitive ELISA kits. RESULTS: Plasma sRAGE levels were significantly lower (p < 0.05) while VCAM-1 levels were significantly higher (p < 0.05) in poorly controlled diabetic patients compared with healthy control. Blood GSH levels were significantly lower in diabetic patients compared with healthy control (p < 0.05). Plasma C-peptide, NOx, ox-LDL levels, and SOD activity were not significantly different in diabetic patients compared with healthy control. Plasma levels of sRAGE were negatively associated with circulating VCAM-1 levels in diabetic patients. CONCLUSION: Poor glycemic control decreases plasma sRAGE and increases VCAM-1 levels while good glycemic control improves these abnormalities which provides benefit to diabetic patients.